Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-26 @ 2:08 AM
Study NCT ID:
NCT01314105
Status:
COMPLETED
Last Update Posted:
2025-02-13
First Post:
2011-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
Sponsor:
Boehringer Ingelheim